Compare Citigroup Inc. (C) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citigroup Inc. vs Moderna, Inc. — how do they compare? Citigroup Inc. trades at $135.95 (market cap $227.75B), while Moderna, Inc. trades at $60.77 (market cap $24.18B). The key difference: Citigroup Inc. is far larger — about 9.4× Moderna, Inc.'s market cap, and Citigroup Inc. pays a 1.97% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| C | MRNA | |
|---|---|---|
Market Cap | $227.75B | $24.18B |
Sector | Financials | Health |
52-Week High | $145.67 | $81.80 |
52-Week Low | $92.59 | $22.36 |
Dividend Yield | 1.97% | — |
Enterprise Value | — | $20.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citigroup Inc.
Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.
Read more on C →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
